CN Stock MarketDetailed Quotes

Sichuan Kelun Pharmaceutical (002422)

Watchlist
  • 34.00
  • -0.13-0.38%
Not Open Apr 10 15:00 CST
54.33BMarket Cap31.92P/E (TTM)

Sichuan Kelun Pharmaceutical (002422) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Non infusion8.87B47.90%
Infusion7.48B40.43%
Research and development projects1.51B8.17%
Other business648.53M3.50%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing16.35B88.32%
Research and development projects1.51B8.17%
Other business648.53M3.50%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China5.01B27.08%
Southwest3.7B19.98%
International business2.49B13.44%
Central China2.22B12.00%
North China1.69B9.12%
South China1.43B7.73%
Northwest742.01M4.01%
Other business648.53M3.50%
Northeast China580.96M3.14%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More